Diabetes type2. oral antidiabetic drugs
Conditions
Interventions
Intervention 1: Intervention group: 70 patients in adition to metformin 500 mg tablets (one every 12 hours), palm kernel plate, are given one 200 mg capsule every 12 hours for 90 days. Intervention 2:
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Having type 2 diabetes Less than 6 months have passed since the onset of the disease Fasting blood sugar is less than 200 and HbA1C is less than 9 Age 30-60 years
Exclusion criteria
Exclusion criteria: Pregnant or lactating patient Age under 30 or over 60 years Advanced complications of diabetes Patients undergoing chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar, HbA1C ,2-hour blood sugar. Timepoint: Measurement of fasting blood sugar, HbA1C .Blood sugar 2 hours at the beginning of the study and after 3 months. Method of measurement: Blood glucose measuring device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Farhangian
Ahvaz University of Medical Sciences
Outcome results
None listed